GM Advisory Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$282K Buy
4,493
+673
+18% +$53.8K 0.01% 306
2025
Q4
$364K Buy
3,820
+120
+3% +$11.8K 0.01% 254
2025
Q3
$361K Buy
3,700
+1,612
+77% +$167K 0.02% 229
2025
Q2
$224K Sell
2,088
-160
-7% -$16.2K 0.01% 266
2025
Q1
$227K Buy
+2,248
New +$226K 0.01% 242

Other funds holding BSX

GM Advisory Group's BSX Position: Q1 2026 in Review

GM Advisory Group increased its Boston Scientific (BSX) stake by 18% in Q1 2026, buying an estimated $53.8K and bringing the position to 4,493 shares worth $282K. The position accounts for 0.01% of the portfolio, ranked #306.

GM Advisory Group first reported a position in BSX in Q1 2025 and has held it in 5 quarters since. The position peaked at $364K in Q4 2025. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • GM Advisory Group held 4,493 shares of Boston Scientific worth $282K as of Q1 2026.
  • GM Advisory Group bought 673 Boston Scientific shares in Q1 2026, an estimated $53.8K.
  • Boston Scientific made up 0.01% of GM Advisory Group's portfolio in Q1 2026, its #306 holding.
  • GM Advisory Group first reported a position in Boston Scientific in Q1 2025 and has held it in 5 quarters since.
  • GM Advisory Group's Boston Scientific position peaked at $364K in Q4 2025.
  • 1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on GM Advisory Group's 13F filing for Q1 2026, filed 28 Apr 2026.